期刊文献+

奥沙利铂长循环脂质体制备工艺优选 被引量:2

Technological Optimization on Preparation of Oxaliplatin Long-circulating Liposome
在线阅读 下载PDF
导出
摘要 目的研究奥沙利铂长循环脂质体的处方筛选和制备工艺,并研究其稳定性。方法采用乙醇注入法制备奥沙利铂长循环脂质体,以包封率为评价指标,采用正交设计优化处方和制备工艺,高效液相色谱法测定脂质体包封率。结果最佳工艺处方为卵磷脂与胆固醇质量比5∶1,奥沙利铂10 mg,聚乙二醇2000浓度0.05%,平均包封率(51.87±0.90)%。结论该制备方法较简单,经优化制备的奥沙利铂长循环脂质体处方合理,工艺可行,稳定性好。 Objective To optimize technology on preparation of oxaliplatin long-circulating liposome. Methods The liposome was prepared by ethanol injection method. Orthogonal design was used to optimize the prescription and preparation. Encapsulate rate of the liposome was determined by high performance liquid chromatography. Results The optimum prescription was as follows: the quality ratio of lecithin to cholesterol was 5 : 1, the amount of oxaliplatin was 10 mg, and the concentration of polyethylene glycol 2000 was 0.05% , the average coating rate is (51.87± 0.90 )%. Conclusion The optimized formulation of PEG2000-conjugated oxaliplatin long-circulating liposome is reasonable, oracticable and stable.
出处 《医药导报》 CAS 北大核心 2013年第5期660-663,共4页 Herald of Medicine
基金 中央高校基本科研业务费专项资金资助(Whut-2011-IV-023) 武汉市青年科技晨光计划项目资助(201271031391)
关键词 奥沙利铂 脂质体 长循环 聚乙二醇2000 Oxaliplatin Liposomes Long-circulating PEG2000
  • 相关文献

参考文献4

二级参考文献37

共引文献23

同被引文献21

  • 1洪慧,龙晓英,李力任,林丹,梁少华.葡聚糖微型凝胶柱测定辣椒碱柔性脂质体包封率的条件探讨[J].广东药学院学报,2005,21(2):120-123. 被引量:29
  • 2吴琼,程小卫,雷光青,陈士明,陈家宽,周铜水.仙茅苷对自由基的清除作用[J].中国现代应用药学,2007,24(1):6-9. 被引量:16
  • 3秦晶,陈大为,乔明曦,胡海洋,赵秀丽,陈宝玉.微柱离心法测定阿魏酸脂质体的包封率[J].中国药学杂志,2007,42(14):1116-1117. 被引量:22
  • 4KOBAYASHI Y, TAGAWA N, SAIKI K, et al. Studies on steroids in fetuses and neonates:identification of 16-dehy- dropregnenolone in the circulation of preterm neonates [ J ]. Biol Pharm Bull, 1994, 17 (11 ) :1501-1504.
  • 5LING Y Z,LI J S,KATO K,et al. Synthesis and in vitro ac- tivity of some epimeric 20 ct-hydroxy, 20-oxime and aziri- dine pregnene derivatives as inhibitors of human 17a- hydrxylase/C17,20-1yase and 5c-reductase [ J ]. Bioorg Med Chem, 1998, 6(10) :1683-1693.
  • 6PRATAP R, GUPTA R C, CHANDER R, et al. Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones: EP, 99302556.8 [ P]. 2000-07-19.
  • 7SUN L X, FU W W, REN J, et al. Cytotoxic constituents from solanum lyratum [ J]. Arch Pharm Res, 2006, 29 (2) :135-139.
  • 8MA E L,ZHAO D M, LI Y C, et al. Activation of ATM- Chk2 by 16-dehydropregnenolone induces G1 phase arrest and apoptosis in HeLa cells [ J ]. J Asian Nat Prod Res, 2012,14(9) :817-825.
  • 9SURYAWANSHI S, WAHAJUDDIN, GUPTA R C, et al. Prechnical pharmacokinetics, dose proportionality, gender difference and protein binding study of 16-dehydropreg- nenolone, an antihyperlipidemic agent, in rats [ J ]. J Pharm Pharmaeol, 2011 , 63 ( 1 ) :41-48.
  • 10CHEN C J, HAND D, CAI C F, et al. An overview of li- posome lyophilization and its future potential [ J ]. J Control Release ,2010,142( 3 ) :299-311.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部